Our Partnerships

We are enormously grateful for the support of our industry partners, whose contributions make the BICCS Annual Conference possible. Our industry collaborations drive progress in cardiology through pioneering research, cutting edge treatments, and progressive educational initiatives.

The Cardiovascular Rare Disease Node unites UK researchers, clinicians, and patients to advance understanding of rare inherited cardiovascular conditions. By integrating NHS clinical and genomic data, the Node aims to overcome current diagnostic limitations and improve patient care. Working with NHS England, Genomics England, the BHF Data Science Centre and patient organisations, it will create a secure research environment and participant registry to accelerate discovery and therapeutic studies.

Lead Contact: Professor James Ware, Imperial College London/ MRC Laboratory of Medical Sciences. Co-Directors: Dr Tom Lumbers, UCL & Dr Kate Thompson, Oxford. Join the mailing list by contacting cardiovascular@rd-research.org.uk.

The Heart Hive is a direct-to-participant website supporting patient-driven research participation. Lots of people want to take part in research, but don’t know how. We have a growing registry of people living with cardiomyopathy or myocarditis who are interested in taking part in studies. Our mission is to connect them with researchers, to accelerate research and improve future care. Studies can be listed on the Heart Hive by any researcher with an ethically approved project and a recognised sponsoring institution. Patients from across the UK and their relatives can register. Find out more on their website or email info@thehearthive.org.

“Every week in the UK, at least 12 young people die from undiagnosed heart conditions. Since 1995, Cardiac Risk in the Young (CRY) has worked tirelessly to reduce the incidence of young sudden cardiac death (YSCD). CRY provides support for young people diagnosed with life-threatening cardiac conditions and offers specialist bereavement services for families affected by YSCD. The charity promotes and delivers cardiac screening programs, funds vital medical research, and publishes accessible information written by leading cardiologists. CRY also supports specialist referral, screening, and cardiac pathology services at major UK hospitals, striving to save lives and raise awareness nationwide.”

Cardiomyopathy UK is the specialist charity supporting people affected by cardiomyopathy – a disease of the heart muscle. Our vision is that people affected by cardiomyopathy should live a long and fulfilling life. We offer clear, compassionate support and information to help people feel more informed about their condition, less scared and better able to cope day to day. We also educate healthcare professionals so that they are better able to detect and treat the condition and work to raise awareness of the signs and symptoms of cardiomyopathy among the public, so that more people seek help. We bring together the patient community, leading clinicians, researchers, policy makers and other key stakeholders to work collaboratively on tackling the issues that people affected by cardiomyopathy face – now and in the future.

Whilst our industry partners have contributed towards the costs of this conference through sponsorship, they have had no involvement in the agenda, speaker selection or scientific content of this conference, excluding dedicated industry symposia.